Navigation Links
iSirona Signs Reference Selling Agreement with NxStage
Date:2/27/2009

Relationship Expected to Result in Improved Nursing Productivity in the Treatment of Renal Disease

Panama City, Fla. (PRWEB) February 27, 2009 -- iSirona®, an innovative provider of data automation solutions for healthcare providers, today announced that it has signed an agreement with NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products. Under the agreement, iSirona will develop the iSirona Gateway for the NxStage System One™ renal dialysis system.

The iSirona gateway is being developed to allow NxStage customers to integrate critical data from their NxStage products into their hospital information systems. Once completed, the gateway will allow critical care facilities to leverage the NxStage System One's robust data collection capabilities and take advantage of iSirona's proprietary Positive Patient Identification logic. This will ensure that patient data retrieved from a device is accurately linked to the correct patient.

"The NxStage System One is a robust and innovative solution, offering treatment flexibility and ease of use to caregivers in the critical care setting," states Jeffrey H. Burbank, CEO of NxStage Medical, Inc. "We look forward to working with iSirona with the goal of delivering increased return on investment and benefits to System One customers within the critical care market."

"We are excited to work with NxStage in delivering connectivity between the System One and clinical information systems such as the EMR," says Peter Witonsky, iSirona's president and chief sales officer. "Not only will this functionality ensure that the data is documented to the correct patient, it will improve the speed and accuracy of data available for clinical review and decision making."

About NxStage Medical:
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company headquartered in Lawrence, Massachusetts that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at http://www.nxstage.com.

About iSirona:
Panama City, Florida-based iSirona (www.isirona.com) develops clinical automation solutions for healthcare. The iSirona Enterprise™ product suite delivers medical device data from bedside and mobile devices to clinical information systems, simplifying the process of patient data collection. iSirona accelerates return-on-investment by streamlining workflow and maximizing IT investments. Uniquely positioned to deliver the most robust solution, iSirona guarantees delivery of accurate, timely and complete patient data.

###

Read the full story at http://www.prweb.com/releases/patientdata/renaldisease/prweb2190954.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. iSirona Announces New President and Chief Sales Officer
2. Jefferson Regional Medical Center Selects iSirona DeviceConX for Medical Device Integration
3. Pot bellies linked to early signs of cardiovascular disease
4. MSU engineering team designs innovative medical device
5. Jump in Youth Suicide Prompts National Childrens Charity KidsPeace to Issue Tips on Prevention, Warning Signs
6. Thomson Scientific Signs Multi-Year Agreement with The Council for Scientific and Industrial Research (CSIR)
7. Gov. Blagojevich Signs Bill Improving Illinois Mental Illness Treatment Law
8. A new technology for cancer screening listens for the signs of cancer
9. ReBuilder Medical Technologies, Inc. Signs Agreement for Distribution in Maine
10. Pearson VUE Signs Exclusive Contract with Educational Resources, Inc.
11. Former Ronco President Tim Dupler Signs International Direct Sales and Marketing Contract with Natural Nutrition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... VA (PRWEB) , ... March 28, 2017 , ... The ... Still, MHA, FRBMA, has begun to serve as its new executive director. Mr. Still ... the Executive Search Committee. , “Bob, as he is known to our members, ...
(Date:3/28/2017)... ... March 28, 2017 , ... Neurotechnology , ... biometric time and attendance tracking products: the new NCheck Cloud Bio Attendance cloud-based ... Attendance uses biometric face recognition to enable users to check in and out ...
(Date:3/28/2017)... St. Petersburg Florida (PRWEB) , ... March 28, 2017 , ... ... U.S. Marine Corp to raise money to for the Toys for Tots Literacy Campaign ... a federal budget in excess of $70 billion, the U.S. ranks at number 14 ...
(Date:3/28/2017)... ... March 28, 2017 , ... Prominant ... Surgical, Inc. is thrilled to offer the recently FDA-approved Obalon Balloon System to ... adds to SkyLex Advanced Surgical’s already comprehensive list of weight-loss services. Dr. ...
(Date:3/28/2017)... ... ... Silicon Valley Hair Institute, the San Francisco Bay Area leader in women's ... loss. Although hair transplant procedures can be seen as more of a man’s issue, ... two reasons a woman may see her hair thinning. , “We are used to ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017  Akcea Therapeutics, a subsidiary ... to the company,s board of directors: ... Partners. Mr. Gabrieli will serve as chairman of the board ... former chief commercial officer of Forest Laboratories. ... Biolink Partners. "We are excited to ...
(Date:3/28/2017)... 2017 RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... Patent Office (JPO) for the composition of matter ... for the treatment or prevention of fibrotic disorders, ... proliferative retinopathy (Japanese Patent #: 6060071).  This patent ...
(Date:3/28/2017)... , March 28, 2017  Medeon Biodesign, Inc., ... company, is pleased to announce that the Company ... of Panther Orthopedics, Inc., a San ... fixation solutions for orthopedic extremity applications.  ... expand rapidly, primarily due to procedure volume growth, ...
Breaking Medicine Technology: